Product/Composition:- | Nystatin Topical Creams and Ointments |
---|---|
Strength:- | 100,000 units/g, 100,000–300,000 units/g |
Form:- | Topical Creams and Ointments |
Reference Brands:- | Mycostatin, Nilstat, Nystop(US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Nystatin topical creams and ointments inhibit fungal cell membrane synthesis by binding to ergosterol, disrupting membrane integrity. They effectively treat superficial candidiasis, providing targeted therapy with rapid symptom relief. Benefits include minimal systemic absorption, broad antifungal activity, and safety, making them reliable for treating skin and mucosal fungal infections.
Nystatin topical creams and ointments are approved in the EU and US for treating cutaneous candidiasis. In the EU, brands like Nystan and Mycostatin are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA-approved formulations such as Nystop are backed by clinical data and pharmacovigilance. Both regions require detailed dossiers for approval and safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate efficient market entry for nystatin topical products, ensuring adherence to European and American standards for safe, effective antifungal therapy.